Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 01, 2022	Oct. 02, 2021
Operating activities
Net earnings	$ 27,712	$ 14,455
Adjustments to reconcile net earnings to net cash provided by operating activities:
Impairment of goodwill and indefinite-lived intangibles	0	1,223
Depreciation and amortization	11,519	11,033
Gain on sale of property and equipment	(182)	(35)
Reclassification of foreign currency translation adjustment related to disposal of subsidiary	191	0
Share-based compensation expense	1,583	1,328
Inventory write-offs for obsolescence	1,451	1,613
Deferred income taxes	(72)	(1,412)
Other	(4,319)	(2,022)
Net changes in operating assets and liabilities:
Accounts receivable, net	(2,077)	(3,078)
Inventories, net	(14,151)	(9,624)
Prepaid expenses and other current assets	(984)	(3,591)
Trade accounts payable	(1,459)	3,695
Other current liabilities	1,303	4,496
Net cash provided by operating activities	20,515	18,081
Investing activities
Capital expenditures	(15,545)	(11,191)
Proceeds from sale of property and equipment	397	181
Purchase of business, net of cash acquired	0	(47,216)
Net cash used in investing activities	(15,148)	(58,226)
Financing activities
Principal payments on long-term debt	0	(18)
Proceeds from revolving facility	0	20,000
Purchase of treasury stock	(1,061)	0
Distributions to noncontrolling interests	(366)	(244)
Payments of employee taxes on certain share-based arrangements	(435)	(853)
Net cash (used in) provided by financing activities	(1,862)	18,885
Effect of exchange rate changes on cash and cash equivalents	(7,930)	(1,634)
Decrease in cash and cash equivalents	(4,425)	(22,894)
Cash and cash equivalents at beginning of period	84,335	98,438
Cash and cash equivalents at end of period	79,910	75,544
Supplemental disclosure of investing transactions:
Capital expenditures purchased	(13,198)	(9,368)
Capital expenditures accrued but not yet paid	$ 720	$ 738